Event 
Partner 
Milestone 
2018-12-05
ACTOnco+ received National Innovation Award in Taiwan!
ACTOnco+ won the National Innovation Award in the the Precision Medicine section in Taiwan. ACTOnco+ was awarded for providing actionable solutions to cancer patients around Asia.
Place:
Taiwan
2018-12-04
Come meet us at the Precision Medicine World Conference in Silicon Valley!
Chief Scientific Officer Dr. Shu Jen Chen will be presenting on "Biomarker Solution for Immunotherapy: TMB and Beyond" at the 16th PMWC on Jan 22nd, focusing on TMB and Tumor Micro-environment.
Place:
Silicon Valley, CA
2018-11-24
ACT Genomics Completed Another Round of Equity Financing
ACT Genomics is pleased to announce the completion of the latest round of equity financing from a group of international investors co-led by CLSA Capital Partners to support the establishment of new CAP-accredited lab in HK, as well as R&D effort.
Place:
2018-11-22
Dr. Allen Lai wins the Executive of the Year – Biotechnology award in Singapore
Dr. Allen Lai, Senior Vice President of ACT Genomics, wins the Executive of the Year – Biotechnology award in Singapore Business Review Management Excellence Awards 2018
Place:
Singapore
2018-11-01
Canon Medical partners with ACT Genomics!
Canon Medical System Corporation officially acquired ACT Genomics’ joint venture company in Japan, ACTmed! ACT Genomics will transfer its clinical NGS technology and help operate cancer genomic profiling service in Japan.
Place:
2018-11-01
Nov 28 Upcoming Asia Pacific Lung Cancer Forum
ACT Genomics and Taiwan Lung Cancer Society will hold Asia Pacific Lung Cancer Forum on November 28th at Taipei W hotel.
Place:
Taipei
2018-11-01
Nov 10-11 Last Call to Register for The Upcoming Annual 5th Hong Kong International Oncology Symposium (5th HKIOS)
ACT Genomics has the invaluable opportunity to be one of the sponsors of the 5th Hong Kong International Oncology Symposium (5th HKIOS) from 10th -11th November 2018 at Hong Kong Science and Technology Park (HKSTP) and City University of Hong Kong (CityU)
Place:
Hong Kong
2018-11-01
Nov 09 Friends of Cancer Research Will Present Initial Findings of TMB Hamonization in Washington, D.C.
MB Harmonization oral presentation titled “In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project “ is scheduled on November 9 th
Place:
USA
2018-11-01
Nov 07-11 ACT Genomics Shares Precision Medicine in Immunotherapy at SITC 2018
ACT Genomics introduced how innovative genomic profiling services can improve immunotherapy reponse rate with predictive biomarkers such as tumor mutational burden (TMB) in The 33rd Annual Meeting & Pre-Conference Programs (SITC 2018)
Place:
USA
2018-11-01
Nov 07 Educational Lecture at Kiang Wu Hospital, Macau on NGS Application to Guide Targeted & Immune Therapeutics by Lab Director of ACTG HK
Dr. Timothy T.C. Yip delivered a talk titled “The New Frontier in Precision Oncology Treatment: How Next-Generation Sequencing (NGS) testing can guide the use of targeted & immune drugs in treatment of cancer patients?”
Place:
Hong Kong
